Ascend Theraps Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ASCEND THERAPS US, and what generic and branded alternatives to ASCEND THERAPS US drugs are available?
ASCEND THERAPS US has one approved drug.
Summary for Ascend Theraps Us
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ascend Theraps Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascend Theraps Us | ESTROGEL | estradiol | GEL, METERED;TRANSDERMAL | 021166-002 | Feb 9, 2004 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| Ascend Theraps Us | ESTROGEL | estradiol | GEL;TOPICAL | 021166-001 | Feb 9, 2004 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
